2700078K21Rik Activators are a diverse group of compounds that enhance the functional activity of the protein through various signaling pathways. Forskolin, by increasing intracellular cAMP levels, activates protein kinase A, which may phosphorylate substrates, including those involved in the pathways with 2700078K21Rik, leading to its enhanced activity. Similarly, PMA, as a PKC activator, and Genistein, as a tyrosine kinase inhibitor, both shift cellular signaling in favor of pathways that activate 2700078K21Rik. EGCG, through kinase inhibition, and Sphingosine-1-phosphate, by engaging its receptors, both potentiate the signaling pathways that 2700078K21Rik is a part of, thus enhancing its activity. Ionomycin, by increasing intracellular calcium, activates calcium-dependent proteins and pathways that can lead to the activation of 2700078K21Rik. Akt1 Activators are chemical compounds that enhance Akt1 activity through various mechanisms, primarily by influencing the PI3K/Akt signaling pathway, which is crucial for Akt1 phosphorylation and activation.
Compounds like PD98059 and LY294002, although typically acting as inhibitors for MEK and PI3K, respectively, can indirectly enhance Akt1 activity by reducing negative feedback or through off-target effects that activate compensatory pathways. More direct influences come from SC79, which binds to Akt1 and aids in its localization and activation at the membrane, and A-443654, which directly binds and promotes Akt1 activation. Similarly, honokiol and arctigenin enhance Akt1 activity not by direct binding, but by modulating upstream regulators within the PI3K/Akt pathway. Furthermore, hormonal activators like dihydrotestosterone exert their effects on Akt1 through receptor-mediated activation of the PI3K/Akt pathway. Meanwhile, resveratrol, a polyphenol, indirectly enhances Akt1 activity via activation of sirtuins that modulate the PI3K/Akt pathway. Triciribine, despite its role as an Akt inhibitor, has been observed to activate Akt1 through a feedback mechanism that overcomes the initial inhibition.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC phosphorylates target proteins, which can result in the activation of downstream signaling pathways that include 2700078K21Rik, thereby enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases, potentially reducing negative regulatory influences on pathways involving 2700078K21Rik, thus leading to its enhanced activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages with its receptors to activate intracellular signaling cascades, including those that may involve 2700078K21Rik, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as a calcium ionophore, increasing intracellular calcium levels. This rise in calcium can activate calcium-dependent proteins and pathways that enhance the activity of 2700078K21Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream signaling pathways. By inhibiting PI3K, LY294002 may remove inhibitory signals allowing pathways that activate 2700078K21Rik to be more active. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK. Inhibition of p38 may shift the balance of cellular signaling towards pathways that activate 2700078K21Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can lead to the activation of signaling pathways by reducing competition from tyrosine kinase signaling, thereby enhancing the activity of 2700078K21Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor which leads to increased cytosolic calcium levels. Elevated calcium can activate signaling pathways that result in the enhancement of 2700078K21Rik activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, which may selectively activate pathways involving 2700078K21Rik by reducing the inhibitory phosphorylation of proteins within these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which by inhibiting PI3K, may enhance the activity of 2700078K21Rik by favoring the activation of alternative signaling pathways. | ||||||